期刊
PSYCHO-ONCOLOGY
卷 26, 期 12, 页码 2294-2299出版社
WILEY
DOI: 10.1002/pon.4362
关键词
cancer; depression; medication adherence; oncology; physical functioning
资金
- National Cancer Institute [CA97916-01]
ObjectiveDespite the efficacy of clinical treatments (eg, adjuvant hormonal therapy) for breast cancer survivors (BCS), nonadherence rates remain high, increasing the risk of recurrence and mortality. The current study tested a theoretical model of medical nonadherence that proposes depression to be the most proximal predictor of medical nonadherence among BCS. MethodsBreast cancer survivors were recruited from radiation clinics in Missouri. Survey data were collected 12months after the end of primary treatment. The sample size included 133 BCS. ResultsFindings show substantial support for the model, demonstrating that depression mediated the relation between physical symptoms, cognitive symptoms, social support, and adherence to medication. This finding was replicated with a measure of mood disturbance. ConclusionsThese findings support the prediction that medication nonadherence among BCS multiply determined process and have compelling implications for healthcare providers and interventions designed to increase medication adherence among BCS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据